Preferred Name |
Indinavir |
|
Synonyms |
(1(1S,2R),5(S))-2,3,5-Trideoxy-N-(2,3-dihydro-2-hydroxy-1H-inden-1-yl)-5-(2-(((1,1-dimethylethyl)amino)carbonyl)-4-(3-pyridinylmethyl)-1-piperazinyl)-2-(phenylmethyl)-D-erythro-Pentonamide Compound J IDV INDINAVIR Indinavir indinavir |
|
Definitions |
A synthetic hydroxyaminopentane amide agent that selectively inhibits the protease of both human immunodeficiency virus 1 and 2. The incorporation of a basic amine into the hydroxyethylene backbone improves its aqueous solubility and its oral bioavailability. |
|
ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C66877 |
|
ALT_DEFINITION |
A drug that interferes with the ability of a virus to make copies of itself. |
|
CAS_Registry |
180683-37-8 |
|
Chemical_Formula |
C36H47N5O4.H2O |
|
code |
C66877 |
|
Concept_In_Subset | ||
Contributing_Source |
FDA |
|
DEFINITION |
A synthetic hydroxyaminopentane amide agent that selectively inhibits the protease of both human immunodeficiency virus 1 and 2. The incorporation of a basic amine into the hydroxyethylene backbone improves its aqueous solubility and its oral bioavailability. |
|
FDA_UNII_Code |
5W6YA9PKKH |
|
FULL_SYN |
(1(1S,2R),5(S))-2,3,5-Trideoxy-N-(2,3-dihydro-2-hydroxy-1H-inden-1-yl)-5-(2-(((1,1-dimethylethyl)amino)carbonyl)-4-(3-pyridinylmethyl)-1-piperazinyl)-2-(phenylmethyl)-D-erythro-Pentonamide Compound J IDV INDINAVIR Indinavir indinavir |
|
Has_Salt_Form | ||
label |
Indinavir |
|
Legacy Concept Name |
Indinavir_Base |
|
Preferred_Name |
Indinavir |
|
prefixIRI |
Thesaurus:C66877 |
|
Semantic_Type |
Pharmacologic Substance |
|
UMLS_CUI |
C0376637 |
|
subClassOf |